GlassScriptPhysician profile
Mario Longoria
NPI 1578542460
$12,727.86
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,378 · 2021: $150 · 2022: $12.95 · 2023: $6,134 · 2024: $53.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,000 · Food and Beverage: $187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,000.00 |
| Food and Beverage | $186.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,000.00 | 2019-2023 | Davinci Xi |
| Medtronic, INC. | $165.41 | 2021-2024 | Reliatack, Ligasure, Progrip |
| Edwards Lifesciences Corporation | $139.05 | 2019 | |
| Covidien LP | $117.50 | 2019 | |
| Smith+Nephew, INC. | $94.51 | 2019-2021 | |
| Integra Lifesciences Corporation | $77.91 | 2021-2022 | |
| Portola Pharmaceuticals, LLC | $34.22 | 2019 | |
| Davol INC. | $29.93 | 2021 | |
| Zimmer Biomet Holdings, INC. | $27.01 | 2023 | Advantagerib |
| Mimedx Group, INC. | $26.18 | 2024 | |
| Tela Bio, INC. | $16.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mario Longoria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.